491 related articles for article (PubMed ID: 26590657)
1. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
[TBL] [Abstract][Full Text] [Related]
2. Differentiate aquaporin-4 antibody negative neuromyelitis optica spectrum disorders from multiple sclerosis by multimodal advanced MRI techniques.
Zhang N; Sun J; Wang Q; Qin W; Zhang X; Qi Y; Yang L; Shi FD; Yu C
Mult Scler Relat Disord; 2020 Jun; 41():102035. PubMed ID: 32200338
[TBL] [Abstract][Full Text] [Related]
3. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.
Kuchling J; Backner Y; Oertel FC; Raz N; Bellmann-Strobl J; Ruprecht K; Paul F; Levin N; Brandt AU; Scheel M
Neuroimage Clin; 2018; 19():538-550. PubMed ID: 29984162
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
[TBL] [Abstract][Full Text] [Related]
5. Relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis: differentiation at diffusion-tensor MR imaging of corpus callosum.
Yu CS; Zhu CZ; Li KC; Xuan Y; Qin W; Sun H; Chan P
Radiology; 2007 Jul; 244(1):249-56. PubMed ID: 17522347
[TBL] [Abstract][Full Text] [Related]
6. Microstructural white matter abnormalities in multiple sclerosis and neuromyelitis optica spectrum disorders: Evaluation by advanced diffusion imaging.
Kato S; Hagiwara A; Yokoyama K; Andica C; Tomizawa Y; Hoshino Y; Uchida W; Nishimura Y; Fujita S; Kamagata K; Hori M; Hattori N; Abe O; Aoki S
J Neurol Sci; 2022 May; 436():120205. PubMed ID: 35259556
[TBL] [Abstract][Full Text] [Related]
7. Multimodal magnetic resonance imaging quantification of gray matter alterations in relapsing-remitting multiple sclerosis and neuromyelitis optica spectrum disorder.
Andica C; Hagiwara A; Yokoyama K; Kato S; Uchida W; Nishimura Y; Fujita S; Kamagata K; Hori M; Tomizawa Y; Hattori N; Aoki S
J Neurosci Res; 2022 Jul; 100(7):1395-1412. PubMed ID: 35316545
[TBL] [Abstract][Full Text] [Related]
8. Evoked potentials are useful for diagnosis of neuromyelitis optica spectrum disorder.
Ohnari K; Okada K; Takahashi T; Mafune K; Adachi H
J Neurol Sci; 2016 May; 364():97-101. PubMed ID: 27084224
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
Keller A; Leidinger P; Meese E; Haas J; Backes C; Rasche L; Behrens JR; Pfuhl C; Wakonig K; Gieß RM; Jarius S; Meder B; Bellmann-Strobl J; Paul F; Pache FC; Ruprecht K
J Neuroinflammation; 2015 Oct; 12():196. PubMed ID: 26521232
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.
Masuda H; Hirano S; Takahashi N; Hatsugano E; Uzawa A; Uchida T; Ohtani R; Kuwabara S; Mori M
PLoS One; 2017; 12(8):e0184012. PubMed ID: 28846745
[TBL] [Abstract][Full Text] [Related]
11. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
[TBL] [Abstract][Full Text] [Related]
12. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
[TBL] [Abstract][Full Text] [Related]
13. Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
Kim SH; Kwak K; Hyun JW; Joung A; Lee SH; Choi YH; Lee JM; Kim HJ
Eur J Neurol; 2017 Jul; 24(7):966-973. PubMed ID: 28643955
[TBL] [Abstract][Full Text] [Related]
14. The different damage patterns of short-, middle- and long-range connections between patients with relapse-remitting multiple sclerosis and neuromyelitis optica spectrum disorder.
Chen X; Peng Y; Zheng Q; Luo D; Han Y; Luo Q; Zhu Q; Luo T; Li Y
Front Immunol; 2022; 13():1007335. PubMed ID: 36532033
[TBL] [Abstract][Full Text] [Related]
15. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T
Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477
[TBL] [Abstract][Full Text] [Related]
16. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
17. An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue.
Tackley G; Kong Y; Minne R; Messina S; Winkler A; Cavey A; Everett R; DeLuca GC; Weir A; Craner M; Tracey I; Palace J; Stagg CJ; Emir U
Neuroimage; 2021 Sep; 238():118225. PubMed ID: 34062267
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
19. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Matthews L; Marasco R; Jenkinson M; Küker W; Luppe S; Leite MI; Giorgio A; De Stefano N; Robertson N; Johansen-Berg H; Evangelou N; Palace J
Neurology; 2013 Apr; 80(14):1330-7. PubMed ID: 23486868
[TBL] [Abstract][Full Text] [Related]
20. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.
van Rooij LC; Wattjes MP; de Jong BA; van Oosten BW
Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
